CareDx to Present at UNOS Transplant Management Forum

Rhea-AI Summary

CareDx, Inc. (Nasdaq: CDNA) will exhibit at the 29th Annual UNOS Transplant Management Forum from April 19-22, 2021. On April 20, 2021, at 11:00 a.m. EDT, they will host a symposium titled “Providing Personalized Care for Every Step on the Transplant Journey.” Key topics include pre-transplant care with TX Connect, quality care with XynQAPI, and post-transplant care with AlloSure® dd-cfDNA. CareDx aims to provide integrated digital solutions to improve transplant patient care, highlighted by the recent acquisition of TX Connect.

Company to showcase its latest integrated solutions for improving care across the whole transplant journey

SOUTH SAN FRANCISCO, Calif., April 16, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it will be exhibiting at the 29^th Annual UNOS Transplant Management Forum (TMF), which takes place virtually between April 19-22, 2021.

On April 20, 2021 at 11:00 a.m. EDT, CareDx will be hosting a symposium titled “Providing Personalized Care for Every Step on the Transplant Journey,” which will include the following topics:

• The Transplant Patient
• Pre-transplant Care with TX Connect and XynCare 
• Quality Care with XynQAPI 
• Post-transplant Care with AlloSure® dd-cfDNA

“CareDx is thrilled to join TMF this year and share its comprehensive suite of integrated digital solutions that provide better tools for those who care for transplant patients,” said Kashif Rathore, Senior Vice President, Digital Business, CareDx. “With the recent inclusion of TX Connect into the CareDx family, we now offer solutions at every critical step of the transplant patient journey—from transplant referral to post transplant care.”

About CareDx
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

CONTACTS:
CareDx, Inc.
Sasha King
Chief Marketing Officer
415-287-2393
sking@caredx.com

Investor Relations
Greg Chodaczek
347-610-7010
investor@caredx.com

FAQ

What is the date of CareDx's symposium at the UNOS Transplant Management Forum?

CareDx's symposium is scheduled for April 20, 2021.

What topics will be discussed during the CareDx symposium?

The symposium will cover pre-transplant care with TX Connect, quality care with XynQAPI, and post-transplant care with AlloSure® dd-cfDNA.

What is the focus of CareDx's participation in the UNOS Transplant Management Forum?

CareDx aims to showcase its integrated solutions that enhance care throughout the transplant journey.

Where is the UNOS Transplant Management Forum being held?

The forum takes place virtually from April 19-22, 2021.

What is the stock symbol for CareDx?

The stock symbol for CareDx is CDNA.